Schistosoma mansoni: antigenic secretions and the etiology of egg granulomas in mice.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 4821452)

Published in Exp Parasitol on April 01, 1974

Authors

L M Hang, K S Warren, D L Boros

Articles by these authors

Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med (1979) 10.02

Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med (1970) 4.50

Giardiasis in the mouse: an animal model. Gastroenterology (1976) 4.47

Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol (1967) 4.04

Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development (1996) 3.63

Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol (1975) 2.59

Granulomatous inflammations. Prog Allergy (1978) 2.31

The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy. Am J Pathol (1967) 2.23

Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol (1998) 2.20

A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med (1975) 2.19

Endogenous desensitization: changing host granulomatou response to schistosome eggs at different stages of infection with schistosoma mansoni. Am J Pathol (1968) 2.18

The pathogenesis of "clay-pipe stem cirrhosis" in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am J Pathol (1966) 2.03

The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg (1972) 1.91

Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish. Development (1997) 1.84

Dispersion of papers among journals based on a mathematical analysis of two diverse medical literatures. Nature (1969) 1.79

Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infect Immun (1986) 1.71

Acquired resistance to infection in an animal model of giardiasis. J Immunol (1976) 1.70

Modulation of granulomatous hypersensitivity. II. Participation of Ly 1+ and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice. J Immunol (1981) 1.69

Eosinophils and resistance to Trichinella spiralis. J Exp Med (1977) 1.68

Modulation of granulomatous hypersensitivity. I. Characterization of T lymphocytes involved in the adoptive suppression of granuloma formation in Schistosoma mansoni-infected mice. J Immunol (1979) 1.64

Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg (1974) 1.61

The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum. Am J Pathol (1968) 1.58

Association of lpr gene with graft-vs.-host disease-like syndrome. J Exp Med (1985) 1.56

Granuloma formation around Schistosoma mansoni, S. HAEMATOBIUM, AND S. japonicum eggs. Size and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am J Trop Med Hyg (1970) 1.56

Regulation of granulomatous inflammation in murine schistosomiasis. In vitro characterization of T lymphocyte subsets involved in the production and suppression of migration inhibition factor. J Exp Med (1980) 1.48

Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis (1973) 1.47

The role of chemical mediators in the inflammatory response induced by foreign bodies: comparison with the schistosome egg granuloma. J Exp Med (1970) 1.44

A functional classification of granulomatous inflammation. Ann N Y Acad Sci (1976) 1.44

An application of the Kermack-McKendrick theory to the epidemiology of schistosomiasis. Am J Trop Med Hyg (1970) 1.43

Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg (1980) 1.43

Suppressive effect of a chronic helminth infection, schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A. Infect Immun (1976) 1.42

Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J Clin Invest (1976) 1.41

Lymphokine regulation of granuloma formation in murine schistosomiasis mansoni. Clin Immunol Immunopathol (1993) 1.38

Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol (1977) 1.37

Hepatosplenic schistosomiasis mansoni: an immunologic disease. Bull N Y Acad Med (1975) 1.34

(NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med (1981) 1.34

The inhibition of granuloma formation around Schistosoma mansoni eggs. I. Immunosuppressive drugs. Am J Trop Med Hyg (1967) 1.33

Th ecology of the medical literatures. Am J Med Sci (1972) 1.32

Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol (1997) 1.31

Selective primary health care: an interim strategy for disease control in developing countries. Soc Sci Med Med Econ (1980) 1.31

Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci U S A (1997) 1.30

The Schistosoma mansoni egg granuloma: quantitation of cell populations. J Pathol (1977) 1.29

Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma. J Immunol (1974) 1.29

The secretion of migration inhibitory factor by intact schistosome egg granulomas maintained in vitro. Nature (1973) 1.28

Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon. N Engl J Med (1974) 1.27

Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice. J Immunol (1989) 1.25

Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases. J Infect Dis (1977) 1.25

Retroviral gp70 immune complexes in NZB x NZW F2 mice with murine lupus nephritis. J Exp Med (1981) 1.25

Increased incidence of hepatoma in mice with chronic schistosomiasis mansoni treated with a carcinogen. Am J Pathol (1967) 1.23

Calcium extrusion is critical for cardiac morphogenesis and rhythm in embryonic zebrafish hearts. Proc Natl Acad Sci U S A (2005) 1.21

Algorithms in the Diagnosis and Management of Exotic Diseases. ii. Giardiasis. J Infect Dis (1975) 1.21

Schistosoma mansoni soluble egg antigens. I. Identification and purification of three major antigens, and the employment of radioimmunoassay for their further characterization. J Immunol (1976) 1.21

Morbidity in Schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya. Am J Trop Med Hyg (1976) 1.19

Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ (1976) 1.19

Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med (1975) 1.18

Rapid, accurate quantification of schistosome eggs via nuclepore filters. J Parasitol (1976) 1.18

The Schistosoma japonicum egg granuloma. II. Cellular composition, granuloma size, and immunologic concomitants. Am J Trop Med Hyg (1978) 1.16

Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii. Nature (1976) 1.16

Antieosinophil serum and the kinetics of eosinophilia in Schistosomiasis mansoni. J Exp Med (1975) 1.15

Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection. Infect Immun (2001) 1.14

Fc-receptor-bearing macrophages isolated from hypersensitivity and foreign-body granulomas. Delineation of macrophage dynamics, fc receptor density/avidity and specificity. Am J Pathol (1979) 1.12

Recombinant IL-2 therapy reverses diminished granulomatous responsiveness in anti-L3T4-treated, Schistosoma mansoni-infected mice. J Immunol (1990) 1.12

Production of a rabbit antimouse eosinophil serum with no cross-reactivity to neutrophils. J Exp Med (1973) 1.11

Schistosomiasis haematobia in coast province Kenya. Relationship between egg output and morbidity. Am J Trop Med Hyg (1979) 1.11

Liver collagen synthesis in murine schistosomiasis. J Clin Invest (1977) 1.11

The humanities in medical education. Ann Intern Med (1984) 1.11

Morbidity in relation to intensity of infection in Opisthorchiasis viverrini: study of a community in Khon Kaen, Thailand. Am J Trop Med Hyg (1982) 1.10

The bentonite granuloma. Characterization of a model system for infectious and foreign body granulomatous inflammation using soluble mycobacterial, histoplasma and schistosoma antigens. Immunology (1973) 1.10

Inhibition of granuloma formation around Schistosoma mansoni eggs. IV. X-irradiation. Am J Pathol (1969) 1.09

An ultrastructural study of hepatic granulomas and schistosome egg shells in murine hepatosplenic schistosomiasis mansoni. Exp Mol Pathol (1967) 1.08

IL-4 influences IL-2 production and granulomatous inflammation in murine schistosomiasis mansoni. J Immunol (1992) 1.08

New scientific opportunities and old obstacles in vaccine development. Proc Natl Acad Sci U S A (1986) 1.06

Algorithms in the diagnosis and management of exotic diseases. xxii. ascariasis and toxocariasis. J Infect Dis (1977) 1.06

Population dynamics of T and B lymphocytes in the lymphoid organs, circulation, and granulomas of mice infected with Schistosoma mansoni. Am J Trop Med Hyg (1979) 1.05

Utilization of fractionated soluble egg antigens reveals selectively modulated granulomatous and lymphokine responses during murine schistosomiasis mansoni. Infect Immun (1992) 1.05

Purified antigen radioimmunoassay in serological diagnosis of schistosomiasis mansoni. Lancet (1977) 1.04

In vivo suppression by cholera toxin of cell-mediated and foreign body inflammatory responses. J Immunol (1974) 1.03

The lymphokine eosinophil stimulation promoter and human schistosomiasis mansoni. J Infect Dis (1975) 1.03

Cercariae of Schistosoma mansoni and plants: attempt to penetrate Phaseolus vulgaris and Hedychium coronarium produces a cercaricide. Nature (1968) 1.03

A controlled study of morbidity of schistosomiasis mansoni in St. Lucian children, based on quantitative egg excretion. Am J Trop Med Hyg (1974) 1.02

Specific granulomatous hypersensitivity elicited by bentonite particles coated with soluble antigens from schistosome eggs and turcle bacilli. Nature (1971) 1.02

Selective primary health care: strategies for control of disease in the developing world. I. Schistosomiasis. Rev Infect Dis (1982) 1.02

The secret of the immunopathogenesis of schistosomiasis: in vivo models. Immunol Rev (1982) 1.02

The Schistosoma japonicum egg granuloma. Am J Pathol (1975) 1.01

Factors that modify the cellular-immune response in patients infected by Schistosoma mansoni. J Immunol (1980) 1.01

Induction of granulomatous and elicitation of cutaneous sensitivity by partially purified SEA of Schistosoma mansoni. J Immunol (1977) 1.01

In vivo microscopic observations of the pathogenesis and pathophysiology of hepatosplenic schistosomiasis in the mouse liver. Am J Trop Med Hyg (1972) 0.99

Comparison of Fc, C3 receptors and Ia antigens on the inflammatory macrophage isolated from vigorous or immunomodulated liver granulomas of schistosome-infected mice. J Reticuloendothel Soc (1981) 0.99

The eosinophil stimulation promoter test in murine and human Trichinella spiralis infection. J Infect Dis (1976) 0.98

Immunoregulation in chronic infectious disease: schistosomiasis as a model. J Invest Dermatol (1978) 0.98

Genetic steps to organ laterality in zebrafish. Comp Funct Genomics (2001) 0.98